|
1 Qie MR．Treatment progress of endometrisis[J/CD]．Chin J Obstet Gynecol Pediatr (Electron Ed), 2008, 4(4): 288－293．[郄明蓉．子宫内膜异位症的治疗现状及进展[J/CD]．中华妇幼临床医学杂志：电子版，2008, 4(4): 288－293.]
|
|
2 Lang JH, Leng JH, Zhu L, et al．Diagnosis and treatment guidelines of Endometriosis [N]．China Med Tribune, 2006－07－24．[郎景和，冷金花，朱兰，等．子宫内膜异位症的诊断和治疗规范[N]．中国医学论坛报，2006－07－24.]
|
|
3 Xavier P, Belo L, Beires J, et al. Serum levels of VEGF and TNF－alpha and their association with C－reactive protein in patients with endometriosis [J]. Arch Gynecol Obstet, 2006, 273(4): 227－231.
|
|
4 Bourlev V, Volkov N, Pavlovitch S, et al. Relationship between microvessel density, proliferative activity and expression of vascular endothelial growth factor－A and its receptors in eutopic endometrium and endometriotic lesions[J]. Reproduction, 2006, 132(3): 501－509.
|
|
5 Ferrero S, Ragni N, Remorgida V. Antiangiogenic therapy in endometriosis[J]. Br J Pharmacol, 2006, 149(2): 133－135.
|
|
6 Yu J, Kang JL, Xia W．New development of matrix metalloproteinases and their inhibitors in endometriosis and adenomyosis[J/CD]．Chin J Obstet Gynecol Pediatr (Electron Ed), 2007, 3(4): 227－229.[余佳，康佳丽，夏薇．基质金属蛋白酶及其抑制物与子宫内膜异位症及子宫腺肌病关系的研究新进展[J/CD]．中华妇幼临床医学杂志：电子版，2007, 3(4): 227－229.]
|
|
7 Xavler P, Beires J. Endometriosis clinical aspects: Sub and endometrial blood flow in Patients with endometriosis[J]. Hum Reprod, 2004, 19(2): 1168－1175.
|
|
8 Lu XE, Ning WX, Dong MY, et al. Vascular endothelial growth factor and matrix metalloproteinase－2 expedite formation of endometriosis in the early stage ICR mouse mouse model[J]. Fertil Steril, 2006, 86(Suppl 4): 1175－1181.
|
|
9 Barcz E, Kaminski P, Marianowski L. Serum vascular endothelial growth factor concentration inpatients with endometriosis[J]. Ginekol Pol, 2001, 71(9): 993－998.
|
|
10 Burlev VA, Ilyasova NA, Dvbinskaya ED. Proliferative activity of microvessels and angiogenesis in eutopic endometrium in patients with peritonical endometriosis[J]. Bulletin Experimental Biol Med, 2005, 139: 727－731.
|
|
11 Huang JC, Papasakelariou C, Dawood MY. Epidermal growth factor and basic fibroblast growth factor in peritoneal fluid of women with endometriosis[J]. Fertil Steril, 1996, 65(5): 931－934.
|
|
12 Drenkhahn M, Gescher DM, Wolber EM, et al. Expression of angiopoietin 1 and 2 in ectopic endometrium on the chicken chorio allantoic membrane[J]. Fertil Steril, 2004, 81(Suppl 1): 869－875.
|
|
13 Matsuzaki S, Canis M, Yokomizo R. Expression of erythro－poietin and erythropoietin receptor in peritoneal endometriosis[J]. Hum Reprod, 2003, 18(1): 152－166.
|
|
14 Liu MB, He YL, Peng DX. Expression of vascular endothelial growth factor and endostatin in peritoneal fluid of patients with endometriosis[J]. J First Military Med Univ, 2004, 24(1): 69－71.
|
|
15 Nap AW, Dunselman GA, Griffioen AW, et al. Angiostatic agents prevent the development of endometriosis－like lesions in the chicken chorioallantoic membranes[J]. Fertil Steril, 2005, 83(3): 793－795.
|
|
16 Nap AW, Criffoen AW, Dunselnan GA, et al. Antiangiogenesis therapy for endometriosis[J]. J Clin Endoerinol Metab, 2004, 89(3)：1089－1095.
|
|
17 Becker CM, Sampson DA, Short SM, et al. Short synthetic endostatin peptides inhibit endothelial migration in vitro and endometriosis in a mouse model[J]. Fertil Steril, 2006, 85(1): 71－77.
|
|
18 Becker CM, Sampson DA, Rupnick MA, et al. Endostatin inhibits the growth of endometriotic lesions but does not affect fertility[J]. Fertil Stem, 2005, 84(Suppl 2): 1144－1155.
|